Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by coincollector87on Aug 24, 2018 3:49pm
81 Views
Post# 28514812

Pot stocks rampage amid expectations of more big deals

Pot stocks rampage amid expectations of more big dealshttps://www.marketwatch.com/story/pot-stocks-rampage-amid-expectations-of-more-big-deals-with-traditional-companies-2018-08-24

Pot stocks rampage amid expectations of more big deals with traditional companies

Published: Aug 24, 2018 3:43 p.m. ET

 
 

 

Report says Smirnoff maker is looking for pot partner, after $4 billion investment in Canopy by booze giant Constellation

ROBYN BECK/AFP/Getty Images
Vast majority of Canadian companies looking to take investments or partner with big beverage and pharmaceutical companies.

By

MAXA. CHERNEY

TECH REPORTER

Marijuana stocks were on a rampage Friday, after a report that Smirnoff and Johnnie Walker maker Diageo PLC is in talks with at least three Canadian pot companies with the intent to purchase a stake or initiate a collaboration in one of them, part of a wave of large traditional companies looking to partner with cannabis companies.

Investors pushed Cronos Group Inc. CRON, +15.76%  up 16% in Friday trading, Tilray Inc. TLRY, +11.71% stock gained 15%, and Canopy Growth Corp.CGC, +7.68%  stock surged nearly 10% as the S&P 500 index SPX, +0.63%  added 0.6%. Canadian pot stocks like Aurora Cannabis Inc. ACB, +5.85%  also received a substantial lift in Friday trading.

The potential to strike a deal with an international beverage conglomerate or pharmaceutical company is something of a Holy Grail for Canadian pot makers, the vast majority of which are exploring investment or other partnerships of a similar sort, according to a source familiar with the Canadian cannabis industry. A long sought-after goal, the potential deal with Diageo DEO, +0.52%   reported by BNN Bloomberg citing two anonymous sources, comes amid the $4 billion investment booze giant Constellation Brands Inc. made in Canadian pot-maker Canopy.

Canopy’s deal with Constellation, the first of its size in Canada, has made real for many the possibility that multinational companies looking to strike deals with weed companies are willing to invest billions to stay ahead of competitors.

“If you’re the CEO of an alcohol and beverage company, and if you go a shareholders meeting or a staff meeting, I guarantee the first question you get is going to be: ’What is our cannabis strategy?’,” Canopy Chief Executive Bruce Hinton said in a telephone interview. “I think the world has changed dramatically and it’s changed because of Constellation and Canopy.”

Other big beverage companies such as Molson Coors Brewing Co. TAP, +0.00% have also signaled their interest in the cannabis industry as beer sales drop. In August, Molson said it was forming a joint venture with The Hydropothecary Corp. HEXO, +4.60%  to develop non-alcoholic cannabis-infused beverages for the Canadian market.

–– ADVERTISEMENT ––
 

Legal adult recreational use of cannabis is set to go into effect in Canada in October. It remains illegal under U.S. federal law, though a number of states including California, Colorado and Washington have legalized the drug.

Tilray declined to comment. Aurora and Cronos did not immediately return a request for comment.

 
 

Bullboard Posts